SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 411 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,520 | +36.0% | 117,215 | +11.5% | 0.13% | +21.2% |
| Q1 2024 | $13,613 | +1780.2% | 105,153 | +1300.7% | 0.10% | +1980.0% |
| Q4 2023 | $724 | -93.2% | 7,507 | -91.4% | 0.01% | -95.0% |
| Q3 2023 | $10,596 | +1795.5% | 87,413 | +2056.7% | 0.10% | +1920.0% |
| Q1 2023 | $559 | -97.3% | 4,053 | -97.4% | 0.01% | -98.3% |
| Q4 2022 | $20,347 | -99.3% | 157,025 | +470.8% | 0.30% | +637.5% |
| Q3 2022 | $3,041,000 | -61.6% | 27,510 | -74.0% | 0.04% | -58.8% |
| Q2 2022 | $7,922,000 | +606.1% | 105,687 | +635.6% | 0.10% | +592.9% |
| Q1 2022 | $1,122,000 | -20.0% | 14,368 | -7.7% | 0.01% | -6.7% |
| Q4 2021 | $1,402,000 | +21.4% | 15,564 | +4.7% | 0.02% | +15.4% |
| Q2 2021 | $1,155,000 | -57.5% | 14,862 | -59.3% | 0.01% | -67.5% |
| Q1 2021 | $2,719,000 | +1052.1% | 36,488 | +1414.7% | 0.04% | +207.7% |
| Q1 2020 | $236,000 | -71.8% | 2,409 | -62.8% | 0.01% | -18.8% |
| Q4 2019 | $836,000 | – | 6,476 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |